Hydroxyurea in sickle cell disease: What will it take to change practice?
University of Cincinnati College of Medicine, Ohio 45267-0562, USA. george.atweh@uc.edu
George F
GF
Atweh
D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D004249:DNA Damage; D004311:Double-Blind Method; D004363:Drug Utilization; D057239:Early Termination of Clinical Trials; D005500:Follow-Up Studies; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D010818:Practice Patterns, Physicians'; D016032:Randomized Controlled Trials as Topic; D012042:Registries
D006918:Hydroxyurea